Literature DB >> 21777330

Contrast media enhancement of intracranial lesions in magnetic resonance imaging does not reflect histopathologic findings consistently.

Jeannine Brunner Singh1, Anna Oevermann, Johann Lang, Marc Vandevelde, Marcus Doherr, Diana Henke, Daniela Gorgas.   

Abstract

Certain magnetic resonance (MR) enhancement patterns are often considered to be associated with a specific diagnosis but experience shows that this association is not always consistent. Therefore, it is not clear how reliably contrast enhancement patterns correlate with specific tissue changes. We investigated the detailed histomorphologic findings of intracranial lesions in relation to Gadodiamide contrast enhancement in 55 lesions from 55 patients, nine cats, and 46 dogs. Lesions were divided into areas according to their contrast enhancement; therefore 81 areas resulted from the 55 lesions which were directly compared with histopathology. In 40 of 55 lesions (73%), the histomorphologic features explained the contrast enhancement pattern. In particular, vascular proliferation and dilated vessels occurred significantly more often in areas with enhancement than in areas without enhancement (P = 0.044). In 15 lesions, there was no association between MR images and histologic findings. In particular, contrast enhancement was found within necrotic areas (10 areas) and ring enhancement was seen in lesions without central necrosis (five lesions). These findings imply that necrosis cannot be differentiated reliably from viable tissue based on postcontrast images. Diffusion of contrast medium within lesions and time delays after contrast medium administration probably play important roles in the presence and patterns of contrast enhancement. Thus, histologic features of lesions cannot be predicted solely by contrast enhancement patterns.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777330     DOI: 10.1111/j.1740-8261.2011.01848.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  5 in total

Review 1.  Immune-Mediated Central Nervous System Disease-Current Knowledge and Recommendations.

Authors:  Samantha Vitale; Kari Foss
Journal:  Top Companion Anim Med       Date:  2018-12-04

Review 2.  Advances in diagnostic and treatment modalities for intracranial tumors.

Authors:  P J Dickinson
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

3.  Exclusion of a brain lesion: is intravenous contrast administration required after normal precontrast magnetic resonance imaging?

Authors:  E J Ives; N Rousset; N Heliczer; M E Herrtage; A E Vanhaesebrouck
Journal:  J Vet Intern Med       Date:  2014-01-27       Impact factor: 3.333

4.  "Comet tail sign": A pitfall of post-gadolinium magnetic resonance imaging findings for metastatic brain tumors.

Authors:  Koichi Mitsuya; Yoko Nakasu; Yoshitaka Narita; Satoshi Nakasu; Makoto Ohno; Yasuji Miyakita; Masato Abe; Ichiro Ito; Nakamasa Hayashi; Masahiro Endo
Journal:  J Neurooncol       Date:  2016-02-02       Impact factor: 4.130

5.  Definitive-intent uniform megavoltage fractioned radiotherapy protocol for presumed canine intracranial gliomas: retrospective analysis of survival and prognostic factors in 38 cases (2013-2019).

Authors:  M Debreuque; P De Fornel; I David; F Delisle; M N Ducerveau; P Devauchelle; J L Thibaud
Journal:  BMC Vet Res       Date:  2020-10-31       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.